TransCode Therapeutics sets 2024 annual meeting for June 13, 2024

Transcode Therapeutics, Inc.

2024 annual meeting scheduled for June 13, 2024; record date is April 22, 2024.
Stockholder proposals for proxy inclusion must be received by April 25, 2024.
Director nominations and other business notices also due by April 25, 2024.
Meeting date is more than 30 days after one-year anniversary of 2023 meeting (May 10, 2023).
Deadlines set under Exchange Act Rule 14a-5(f) and Rule 14a-8.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.